NDC 0131-2480

Vimpat

Lacosamide

Vimpat is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Ucb, Inc.. The primary component is Lacosamide.

Product ID0131-2480_09961f9a-b34e-4a30-a965-4627b427a91c
NDC0131-2480
Product TypeHuman Prescription Drug
Proprietary NameVimpat
Generic NameLacosamide
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2009-05-26
Marketing CategoryNDA / NDA
Application NumberNDA022253
Labeler NameUCB, Inc.
Substance NameLACOSAMIDE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
DEA ScheduleCV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0131-2480-35

60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2480-35)
Marketing Start Date2009-05-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0131-2480-35 [00131248035]

Vimpat TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-05-26

NDC 0131-2480-99 [00131248099]

Vimpat TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-05-26

NDC 0131-2480-47 [00131248047]

Vimpat TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022253
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-05-26
Marketing End Date2009-09-24

NDC 0131-2480-60 [00131248060]

Vimpat TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA022253
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-05-26

Drug Details

Active Ingredients

IngredientStrength
LACOSAMIDE200 mg/1

OpenFDA Data

SPL SET ID:9e79b42c-38a3-4b2c-a196-a5a1948250e2
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 809984
  • 809992
  • 809987
  • 809996
  • 809994
  • 809974
  • 809998
  • 993856
  • 810002
  • 810000
  • 809990
  • 881272
  • 881271
  • 995156
  • UPC Code
  • 0301315410714
  • 0301315410707
  • 0301312477352
  • 0301312478359
  • 0301312479356
  • 0301312480352
  • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Vimpat" or generic name "Lacosamide"

    NDCBrand NameGeneric Name
    0131-1810Vimpatlacosamide
    0131-2470Vimpatlacosamide
    0131-2477Vimpatlacosamide
    0131-2478Vimpatlacosamide
    0131-2479Vimpatlacosamide
    70518-0257VimpatVimpat
    0131-5410VimpatVimpat
    0131-2480VimpatVimpat
    70166-617VimpatVimpat
    0121-0992LacosamideLacosamide
    0121-1984LacosamideLacosamide
    0121-2976LacosamideLacosamide
    0121-3968LacosamideLacosamide

    Trademark Results [Vimpat]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIMPAT
    VIMPAT
    87195168 5351761 Live/Registered
    HARRIS FRC CORPORATION
    2016-10-06
    VIMPAT
    VIMPAT
    79073055 3814774 Dead/Cancelled
    Harris FRC Corporation
    2009-07-25
    VIMPAT
    VIMPAT
    77188576 3460602 Live/Registered
    HARRIS FRC CORPORATION
    2007-05-23
    VIMPAT
    VIMPAT
    77016664 not registered Dead/Abandoned
    Schwarz Pharma Inc.
    2006-10-09

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.